VANCOUVER and MINNEAPOLIS, Sept. 16, 2022 (GLOBE NEWSWIRE) — through NewMediaWire — Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) as we speak introduced that its administration group will probably be taking part in the LSI Europe 2022 Emerging MedTech Summit in Hertfordshire, United Kingdom on September 21-24, 2022.
Neovasc’s President and Chief Executive Officer, Fred Colen, will probably be presenting at 11:10 am BST / 6:10 am ET on September 23, 2022. Interested events might view a stay stream of Mr. Colen’s presentation by registering on the LSI web site right here. An electronic mail with login directions will probably be despatched after registering.
About Neovasc Inc.
Neovasc is a specialty medical gadget firm that develops, manufactures, and markets merchandise for the quickly rising cardiovascular market. Its merchandise embody Reducer, for the remedy of refractory angina, which is below medical investigation in the United States and has been commercially accessible in Europe since 2015, and Tiara™ for the transcatheter remedy of mitral valve illness, which is at present below medical investigation in the United States, Canada, Israel and Europe. For extra data, go to: www.neovasc.com.
Forward-Looking Statement Disclaimer
Certain statements in this information launch comprise forward-looking statements inside the which means of the U.S. Private Securities Litigation Reform Act of 1995 and relevant Canadian securities legal guidelines that might not be primarily based on historic truth. When used herein, the phrases anticipate, anticipate, estimate, might, will, ought to, intend, imagine, and comparable expressions, are supposed to establish forward-looking statements. Forward-looking statements might contain, however usually are not restricted to, the Company’s participation on the 2022 Sidoti & Co. Summer Small Cap Virtual Investor Conference and the timing thereof and the rising cardiovascular market. Forward-looking statements are primarily based on estimates and assumptions made by the Company in mild of its expertise and its notion of historic traits, present situations and anticipated future developments, in addition to different elements that the Company believes are acceptable in the circumstances. Many elements might trigger the Company’s precise outcomes, efficiency or achievements to differ materially from these expressed or implied by the forward-looking statements, together with these described in the Risk Factors part of the Company’s Annual Report on Form 20-F and in the Management’s Discussion and Analysis for the three and 6 months ended June 30, 2022 (copies of which can be obtained at www.sedar.com or www.sec.gov ). These elements needs to be thought of fastidiously, and readers mustn’t place undue reliance on the Company’s forward-looking statements. The Company has no intention and undertakes no obligation to replace or revise any forward-looking statements, whether or not on account of new data, future occasions or in any other case.
Contacts
Investors
Mike Cavanaugh
ICR Westwicke
Phone: +1.617.877.9641
[email protected]
Media
Sean Leous
ICR Westwicke
Phone: +1.646.866.4012
[email protected]
